Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.
Saved in:
| Title: | Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer. |
|---|---|
| Authors: | Hummelink, Karlijn1,2 (AUTHOR) k.monkhorst@nki.nl, van der Noort, Vincent3 (AUTHOR), Muller, Mirte2 (AUTHOR), Schouten, Robert D.2 (AUTHOR), van den Heuvel, Michel M.2 (AUTHOR), Thommen, Daniela S.4 (AUTHOR), Smit, Egbert F.2 (AUTHOR), Meijer, Gerrit A.1 (AUTHOR), Monkhorst, Kim1 (AUTHOR) k.monkhorst@nki.nl |
| Source: | PLoS ONE. 7/31/2024, Vol. 19 Issue 7, p1-21. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
